Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid CancersLori J. Wirth, Maria E. Cabanillas, Hyunseok Kang et al.|New England Journal of Medicine|2020Cited by 766
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trialNirav N. Shah, Jennifer R. Brown, Michael Wang et al.|Haematologica|2024Cited by 12